BACKGROUND:Postoperative pain remains a significant challenge following laparoscopy. Aerosolized intraperitoneal local anesthetic (AILA) is a novel method to deliver local anesthetic. The aim was to evaluate aerosolized ropivacaine in pain management following laparoscopic Nissen fundoplication (LNF) and cholecystectomy (LC). METHODS: This prospective randomized double-blinded placebo-controlled trial enrolled consecutive patients undergoing LNF and LC. The treatment group (TG) received intraperitoneal ropivacaine (5 mL 1 % Naropin(®)) at CO2 insufflation via the AeroSurge(®) aerosolizer device through the camera port. The control group (CG) received 5 mL of saline in the same manner. Postoperative shoulder tip pain at rest 6 h postoperatively was the primary study endpoint, with secondary endpoints of shoulder and abdominal pain within the first 24 h, recovery room stay, hospital stay, and postoperative analgesia use. Pain scores were collected using the Verbal Rating Score. RESULTS:Eighty-seven patients were included in the final analysis (TG n = 40, CG n = 47). There was no significant difference between CG and TG at the primary endpoint. In the LC group, AILA significantly reduced shoulder tip pain at rest at 10 (p = 0.030) and 30 min (p = 0.040) and shoulder tip pain on movement at 10 (p = 0.030) and 30 min (p = 0.037). In the LNF group, AILA significantly reduced postoperative abdominal pain at rest at 6 h (p = 0.009). AILA reduced overall incidence of shoulder tip pain in the LC group (11.8 vs. 57.9 %, p = 0.004). CONCLUSION: This study did not demonstrate a significant difference between TG and CG in the primary endpoint, pain at 6 h postoperatively.
RCT Entities:
BACKGROUND:Postoperative pain remains a significant challenge following laparoscopy. Aerosolized intraperitoneal local anesthetic (AILA) is a novel method to deliver local anesthetic. The aim was to evaluate aerosolized ropivacaine in pain management following laparoscopic Nissen fundoplication (LNF) and cholecystectomy (LC). METHODS: This prospective randomized double-blinded placebo-controlled trial enrolled consecutive patients undergoing LNF and LC. The treatment group (TG) received intraperitoneal ropivacaine (5 mL 1 % Naropin(®)) at CO2 insufflation via the AeroSurge(®) aerosolizer device through the camera port. The control group (CG) received 5 mL of saline in the same manner. Postoperative shoulder tip pain at rest 6 h postoperatively was the primary study endpoint, with secondary endpoints of shoulder and abdominal pain within the first 24 h, recovery room stay, hospital stay, and postoperative analgesia use. Pain scores were collected using the Verbal Rating Score. RESULTS: Eighty-seven patients were included in the final analysis (TG n = 40, CG n = 47). There was no significant difference between CG and TG at the primary endpoint. In the LC group, AILA significantly reduced shoulder tip pain at rest at 10 (p = 0.030) and 30 min (p = 0.040) and shoulder tip pain on movement at 10 (p = 0.030) and 30 min (p = 0.037). In the LNF group, AILA significantly reduced postoperative abdominal pain at rest at 6 h (p = 0.009). AILA reduced overall incidence of shoulder tip pain in the LC group (11.8 vs. 57.9 %, p = 0.004). CONCLUSION: This study did not demonstrate a significant difference between TG and CG in the primary endpoint, pain at 6 h postoperatively.
Authors: Mario Bucciero; Pablo M Ingelmo; Roberto Fumagalli; Eric Noll; Andrea Garbagnati; Marta Somaini; Girish P Joshi; Giovanni Vitale; Vittorio Giardini; Pierre Diemunsch Journal: Anesth Analg Date: 2011-09-14 Impact factor: 5.108
Authors: U Maestroni; D Sortini; C Devito; F Pour Morad Kohan Brunaldi; G Anania; L Pavanelli; A Pasqualucci; A Donini Journal: Surg Endosc Date: 2002-05-07 Impact factor: 4.584
Authors: P M Ingelmo; M Bucciero; M Somaini; E Sahillioglu; A Garbagnati; A Charton; V Rossini; V Sacchi; M Scardilli; A Lometti; G P Joshi; R Fumagalli; P Diemunsch Journal: Br J Anaesth Date: 2013-01-04 Impact factor: 9.166
Authors: Bestoun H Ahmed; Aryan Ahmed; Dongfeng Tan; Ziad T Awad; Ali Yousef Al-Aali; John Kilkenny; Frank A Orlando; Abbas Al-Chalabi; Richard Crass; Sadir J Alrawi Journal: Am Surg Date: 2008-03 Impact factor: 0.688
Authors: Jaime Ruiz-Tovar; Juan Gonzalez; Alejandro Garcia; Consuelo Cruz; Sara Rivas; Montiel Jimenez; Carlos Ferrigni; Manuel Duran Journal: Obes Surg Date: 2016-11 Impact factor: 4.129